Literature DB >> 15288383

Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis.

A Joon Yun1, Patrick Y Lee.   

Abstract

Currently the etiology of osteoporosis is attributed to various endocrine, metabolic, and mechanical factors. We hypothesize that many cases of osteoporosis are also partially attributable to a maladaptation of the link between inflammation and bone turnover. We explore the spatial and temporal link between inflammation and osteoporosis in conditions such as aging, menopause, reflex sympathetic dystrophy, HIV, pregnancy, transplantation, and steroid administration. While nutritional and mechanical factors clearly play a role in many of these situations, the spatial and temporal concordance of osteoporosis and inflammation is buttressed by emerging molecular evidence. Modern bone biology of humans may reflect dual functional legacies of mineral storage and structural support. Osteoporosis may result from disequilibrium between structural demand for key minerals and their biologic demand during maladaptive states of inflammation. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288383     DOI: 10.1016/S0306-9877(03)00326-8

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

1.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

Review 2.  Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health.

Authors:  M A Zulet; A Marti; M D Parra; J A Martínez
Journal:  J Physiol Biochem       Date:  2005-09       Impact factor: 4.158

Review 3.  Molecular inflammation: underpinnings of aging and age-related diseases.

Authors:  Hae Young Chung; Matteo Cesari; Stephen Anton; Emanuele Marzetti; Silvia Giovannini; Arnold Young Seo; Christy Carter; Byung Pal Yu; Christiaan Leeuwenburgh
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

4.  Socioeconomic status, race, and bone turnover in the Midlife in the US Study.

Authors:  C J Crandall; D Miller-Martinez; G A Greendale; N Binkley; T E Seeman; A S Karlamangla
Journal:  Osteoporos Int       Date:  2011-08-03       Impact factor: 4.507

5.  The anti-inflammatory effect of Z-Ligustilide in experimental ovariectomized osteopenic rats.

Authors:  Zhaoji Ma; Lunhao Bai
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

6.  Cell-tethered ligands modulate bone remodeling by osteoblasts and osteoclasts.

Authors:  Rebecca S Hayden; Jean-Philippe Fortin; Benjamin Harwood; Balajikarthick Subramanian; Kyle P Quinn; Irene Georgakoudi; Alan S Kopin; David L Kaplan
Journal:  Adv Funct Mater       Date:  2014-01-29       Impact factor: 18.808

7.  Resveratrol supplementation preserves long bone mass, microstructure, and strength in hindlimb-suspended old male rats.

Authors:  Stephanie M Durbin; Janna R Jackson; Michael J Ryan; Joseph C Gigliotti; Stephan E Alway; Janet C Tou
Journal:  J Bone Miner Metab       Date:  2013-05-19       Impact factor: 2.626

8.  The effect of calcium and vitamin D supplementation on osteoporotic rabbit bones studied by vibrational spectroscopy.

Authors:  Athina Lani; Nikolaos Kourkoumelis; Gerasimos Baliouskas; Margaret Tzaphlidou
Journal:  J Biol Phys       Date:  2014-07-09       Impact factor: 1.365

9.  Cordycepin (3'-deoxyadenosine) down-regulates the proinflammatory cytokines in inflammation-induced osteoporosis model.

Authors:  Da-wei Zhang; Zhen-lin Wang; Wei Qi; Wei Lei; Guang-yue Zhao
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Nigella sativa: A Potential Antiosteoporotic Agent.

Authors:  Ahmad Nazrun Shuid; Norazlina Mohamed; Isa Naina Mohamed; Faizah Othman; Farihah Suhaimi; Elvy Suhana Mohd Ramli; Norliza Muhammad; Ima Nirwana Soelaiman
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.